| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $489.5M | +31.8% |
| Cost of Revenue | $108.6M | +17.7% |
| Gross Profit | $380.8M | +36.4% |
| R&D Expense | $128.4M | +13.6% |
| SG&A Expense | $78.6M | +29.5% |
| Operating Income | $18.8M | +336.0% |
| Pre-tax Income | $32.7M | +806.0% |
| Income Tax | -$118.2M | — |
| Net Income | $150.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $494.3M | +210.4% |
| Accounts Receivable | $80.7M | +39.2% |
| Inventory | $9.9M | +22.5% |
| Current Assets | $606.1M | +151.5% |
| Total Assets | $959.7M | +117.3% |
| Current Liabilities | $96.8M | +25.2% |
| Total Liabilities | $411.5M | +395.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $88.6M | +171.8% |
| Capital Expenditures | $1.8M | +51.0% |
| Investing Cash Flow | -$35.3M | -248.7% |
| Financing Cash Flow | $282.1M | +319.3% |
| Free Cash Flow | $86.8M | +176.3% |
| +3411.4% |
| EPS (Basic) | $1.95 | +3350.0% |
| EPS (Diluted) | $1.77 | +3050.0% |
| Stockholders' Equity |
| $548.2M |
| +52.9% |